Design of Peptide Immunotherapies for MHC Class-II-Associated Autoimmune Disorders

Autoimmune disorders, that occur when autoreactive immune cells are induced to activate their responses against self-tissues, affect one percent of the world population and represent one of the top 10 leading causes of death. The major histocompatibility complex (MHC) is a principal susceptibility l...

Descripción completa

Detalles Bibliográficos
Autor principal: Fridkis-Hareli, Masha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3845387/
https://www.ncbi.nlm.nih.gov/pubmed/24324511
http://dx.doi.org/10.1155/2013/826191

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3845387/
https://www.ncbi.nlm.nih.gov/pubmed/24324511
http://dx.doi.org/10.1155/2013/826191

Ejemplares similares